These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6799485)

  • 1. In-vitro studies on SQ 26,776, a new monobactam antibiotic.
    Russell AD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():81-8. PubMed ID: 6799485
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():57-68. PubMed ID: 6799483
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.
    Livermore DM; Williams JD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():29-37. PubMed ID: 6799480
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.
    Percival A; Thomas E; Hart CA; Karayiannis P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():49-55. PubMed ID: 6799482
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():111-22. PubMed ID: 6799479
    [No Abstract]   [Full Text] [Related]  

  • 6. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
    Rogers DT; Russell AD
    J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
    [No Abstract]   [Full Text] [Related]  

  • 7. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():103-10. PubMed ID: 6976960
    [No Abstract]   [Full Text] [Related]  

  • 8. SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.
    Wise R; Andrews JM; Hancox J
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():39-47. PubMed ID: 6799481
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial activity of a new cephalosporin, cefotaxime.
    Russell AD; Rogers DT
    J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y; Husson M; Klastersky J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Aug; 24(2):227-32. PubMed ID: 6605715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-lactamase activity and susceptibilities to antibiotics among some species of bacteria isolated from medical institution between December 1999 and February 2000].
    Tanimoto A; Sadahisa K; Hayashibara T; Yamane Y; Adachi Y; Karino K; Yamauchi Y; Umeki F; Yasunaga M; Moriki S
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():79-85. PubMed ID: 12599531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Nov; 8(5):355-62. PubMed ID: 6798011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial activity of (+)-negamycin prepared by a new method].
    Kono M; O'Hara K; Ohmiya K; Iida H; Kibayashi C; Kasahara K
    Jpn J Antibiot; 1986 Jan; 39(1):247-9. PubMed ID: 3084829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid method for determining the beta-lactamase-inducing potency of drugs.
    Mett H; Oberkirch I; Schacher B
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):669-72. PubMed ID: 3143580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic effect of extracts from Agrimonia-variety].
    Péter HM
    Pharmazie; 1969 Oct; 24(10):632-5. PubMed ID: 4391804
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
    Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.